Literature DB >> 25361769

Greater γ-tocopherol status during acute smoking abstinence with nicotine replacement therapy improved vascular endothelial function by decreasing 8-iso-15(S)-prostaglandin F2α.

Eunice Mah1, Ruisong Pei2, Yi Guo1, Christopher Masterjohn2, Kevin D Ballard3, Beth A Taylor3, Alan W Taylor4, Maret G Traber4, Jeff S Volek5, Richard S Bruno6.   

Abstract

Nicotine replacement therapy (NRT) improves the long-term success rate of smoking cessation, but induces oxidative stress and inflammatory responses that may delay the restoration of vascular endothelial function (VEF). No studies have examined co-therapy of NRT-assisted smoking abstinence with γ-tocopherol (γ-T), a vitamin E form with antioxidant and anti-inflammatory activities, on improvements in VEF. In a randomized, double-blind, placebo-controlled study, healthy smokers (25 ± 1 y old; mean ± SEM) received NRT and abstained from smoking for 24 h with placebo (n = 12) or oral administration of γ-T-rich mixture of tocopherols (γ-TmT; n = 11) that provided 500 mg γ-T. Brachial artery flow-mediated dilation (FMD), and biomarkers of nitric oxide metabolism, antioxidant status, inflammation, and lipid peroxidation [8-iso-prostaglandin F2α stereoisomers (8-iso-15(R)-PGF2α and 8-iso-15(S)-PGF2α)] were measured prior to and after 24 h of smoking abstinence. Smoking abstinence with NRT regardless of γ-TmT similarly decreased urinary naphthol (P < 0.05) without affecting plasma cotinine. γ-TmT increased plasma γ-T by 4-times and the urinary metabolite of γ-T, γ-carboxyethyl-chromanol, by three times. Smoking abstinence with γ-TmT, but not smoking abstinence alone, increased FMD without affecting plasma nitrate/nitrite or the ratio of asymmetric dimethylarginine/arginine. Urinary 8-iso-15(S)-PGF2α decreased only in those receiving γ-TmT and was inversely correlated to FMD (R = -0.43, P < 0.05). Circulating markers of inflammation were unaffected by smoking abstinence or γ-TmT. Short-term NRT-assisted smoking abstinence with γ-TmT, but not NRT-assisted smoking abstinence alone, improved VEF by decreasing 8-iso-15(S)-PGF2α, a vasoconstrictor that was otherwise unaffected by NRT-assisted smoking abstinence.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Vascular endothelial function; flow-mediated dilation; nicotine replacement therapy; smoking cessation; vitamin E

Mesh:

Substances:

Year:  2014        PMID: 25361769      PMCID: PMC4935369          DOI: 10.1177/1535370214556948

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  46 in total

Review 1.  Assessment of flow-mediated dilation in humans: a methodological and physiological guideline.

Authors:  Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-15       Impact factor: 4.733

2.  Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis.

Authors:  Pierre-François Lesault; Laurent Boyer; Gabriel Pelle; Ala Covali-Noroc; Dominique Rideau; Servais Akakpo; Emmanuel Teiger; Jean-Luc Dubois-Randé; Serge Adnot
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

Review 3.  gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.

Authors:  Q Jiang; S Christen; M K Shigenaga; B N Ames
Journal:  Am J Clin Nutr       Date:  2001-12       Impact factor: 7.045

4.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

5.  Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people.

Authors:  Z A Solak; C Kabaroğlu; G Cok; Z Parildar; U Bayindir; D Ozmen; O Bayindir
Journal:  Clin Exp Med       Date:  2005-10       Impact factor: 3.984

Review 6.  Smoking cessation intervention: an evidence-based approach.

Authors:  Rafael Laniado-Laborín
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

Review 7.  Anti-inflammatory properties of alpha- and gamma-tocopherol.

Authors:  Elke Reiter; Qing Jiang; Stephan Christen
Journal:  Mol Aspects Med       Date:  2007-01-11

8.  Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.

Authors:  K E Sorensen; D S Celermajer; D J Spiegelhalter; D Georgakopoulos; J Robinson; O Thomas; J E Deanfield
Journal:  Br Heart J       Date:  1995-09

9.  Supplementation of a γ-tocopherol-rich mixture of tocopherols in healthy men protects against vascular endothelial dysfunction induced by postprandial hyperglycemia.

Authors:  Eunice Mah; Sang K Noh; Kevin D Ballard; Hea Jin Park; Jeff S Volek; Richard S Bruno
Journal:  J Nutr Biochem       Date:  2012-07-25       Impact factor: 6.048

10.  The effects of vitamin E depletion and repletion on prostaglandin dehydrogenase activity in tissues of young rabbits.

Authors:  A C Chan; P V Hegarty; C E Allen
Journal:  J Nutr       Date:  1980-01       Impact factor: 4.798

View more
  3 in total

1.  Effects of acute cigarette smoking on total blood count and markers of oxidative stress in active and passive smokers.

Authors:  E Lymperaki; K Makedou; S Iliadis; E Vagdatli
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

2.  The impact of tetrahydrobiopterin administration on endothelial function before and after smoking cessation in chronic smokers.

Authors:  Beth A Taylor; Amanda L Zaleski; Ellen A Dornelas; Paul D Thompson
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

3.  Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage.

Authors:  Joseph P McElroy; Steven G Carmella; Alisa K Heskin; Mei Kuen Tang; Sharon E Murphy; Sarah A Reisinger; Joni A Jensen; Dorothy K Hatsukami; Stephen S Hecht; Peter G Shields
Journal:  PLoS One       Date:  2019-06-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.